Orbimed Advisors LLC Purple Biotech Ltd. Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.4 - $5.59 $77,932 - $99,010	-17,712 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.75 - $6.72 $51,397 - $92,104	-13,706 Reduced 43.62%	17,712 $86,000
Q1 2021 May 17, 2021	SELL	$3.93 - $6.99 $1.24 Million - $2.2 Million	-314,779 Reduced 90.92%	31,418 $130,000
Q4 2020 Feb 16, 2021	BUY	$3.81 - $4.73 $1.32 Million - $1.64 Million	346,197 New	346,197 $1.32 Million

Ticker PPBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,303,300
Market Cap $63.1M
Description
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.